The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions

被引:277
作者
Lipsitch, M
Bergstrom, CT
Levin, BR
机构
[1] Emory Univ, Dept Biol, Atlanta, GA 30322 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.97.4.1938
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A simple mathematical model of bacterial transmission within a hospital was used to study the effects of measures to control nosocomial transmission of bacteria and reduce antimicrobial resistance in nosocomial pathogens. The model predicts that: (i) Use of an antibiotic for which resistance is not yet present in a hospital will be positively associated at the individual level (odds ratio) with carriage of bacteria resistant to other antibiotics, but negatively associated at the population level (prevalence). Thus inferences from individual risk factors can yield misleading conclusions about the effect of antibiotic use on resistance to another antibiotic. (ii) Nonspecific interventions that reduce transmission of all bacteria within a hospital will disproportionately reduce the prevalence of colonization with resistant bacteria. (iii) Changes in the prevalence of resistance after a successful intervention will occur on a time scale of weeks to months, considerably faster than in community-acquired infections. Moreover, resistance can decline rapidly in a hospital even if it does not carry a fitness cost. The predictions of the model are compared with those of other models and published data. The implications for resistance control and study design are discussed, along with the limitations and assumptions of the model.
引用
收藏
页码:1938 / 1943
页数:6
相关论文
共 57 条
[41]  
Monnet DL, 1998, INFECT CONT HOSP EP, V19, P388
[42]  
Morgenstern H, 1998, MODERN EPIDEMIOLOGY, P459
[43]   ENTEROCOCCI RESISTANT TO MULTIPLE ANTIMICROBIAL AGENTS, INCLUDING VANCOMYCIN - ESTABLISHMENT OF ENDEMICITY IN A UNIVERSITY MEDICAL-CENTER [J].
MORRIS, JG ;
SHAY, DK ;
HEBDEN, JN ;
MCCARTER, RJ ;
PERDUE, BE ;
JARVIS, W ;
JOHNSON, JA ;
DOWLING, TC ;
POLISH, LB ;
SCHWALBE, RS .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) :250-259
[44]  
Nishi JI, 1998, INFECT CONT HOSP EP, V19, P107
[45]   Vancomycin-resistant enterococci in intensive care units - High frequency of stool carriage during a non-outbreak period [J].
Ostrowsky, BE ;
Venkataraman, L ;
D'Agata, EMC ;
Gold, HS ;
DeGirolami, PC ;
Samore, MH .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (13) :1467-1472
[46]  
PRICE DJE, 1970, LANCET, V2, P1213
[47]   Risk factors for the spread of antibiotic-resistant bacteria [J].
Rao, GG .
DRUGS, 1998, 55 (03) :323-330
[48]   Vancomycin-resistant Gram-positive cocci: Risk factors for faecal carriage [J].
Rao, GG ;
Ojo, F ;
Kolokithas, D .
JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) :63-69
[49]   INVIVO SELECTION FOR TRANSMISSIBLE DRUG-RESISTANCE IN SALMONELLA-TYPHI DURING ANTIMICROBIAL THERAPY [J].
SCHWALBE, RS ;
HOGE, CW ;
MORRIS, JG ;
OHANLON, PN ;
CRAWFORD, RA ;
GILLIGAN, PH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :161-163
[50]  
Sebille V, 1997, INFECT CONT HOSP EP, V18, P84